Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 13/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6814948 | 0.88 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL69485 | 0.88 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL20421308 | 0.82 | ESR1 (0.53) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL10335312 | 0.81 | ESR1 (0.56) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL505601 | 0.80 | ESR1 (0.65) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL1237770 | 0.79 | ESR1 (0.51) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL15085255 | 0.79 | ESR1 (0.50) | ESR1ESR2ALDH1A1CYP3A4HPGD | |
| SCHEMBL10771866 | 0.79 | MMP3 (0.58) | ESR1ESR2ALDH1A1CYP3A4KIF11 | |
| SCHEMBL2859474 | 0.79 | BACE1 (0.47) | ESR1ESR2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL10898128 | 0.78 | ALDH1A1 (0.48) | ESR1ESR2ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260050215-A1 | MATERIAL FOR FORMING SUPERFINE PATTERN, PHOTOSENSITIVE RESIN COMPOSITION, PATTERN TREATMENT COMPOSITION AND FORMATION METHOD OF SUPERFINE PATTERN | Advanced Echem Materials Company Limited (TW) | 2026-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260050215-A1 | MATERIAL FOR FORMING SUPERFINE PATTERN, PHOTOSENSITIVE RESIN COMPOSITION, PATTERN TREATMENT COMPOSITION AND FORMATION METHOD OF SUPERFINE PATTERN | SEM1, ASH2L, RAD51 | ESR1 1140/4885ESR2 2362/4885ALDH1A1 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.